Testosterone enhances risk tolerance without altering motor impulsivity in male rats

Psychoneuroendocrinology

Volumn 40, Issue 1, 2014, Pages 201-212

  Cooper, Sarah E ^a,c   Goings, Sydney P ^a,b   Kim, Jessica Y ^a   Wood, Ruth I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Anabolic agents; Go no go; Punishment; Response inhibition; Reward; Risk

Indexed keywords

TESTOSTERONE;

ADOLESCENCE; ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DECISION MAKING; FOOD; FOOTSHOCK; IMPULSIVENESS; LIGHT; LONG EVANS RAT; MALE; MOTOR SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; RISK ASSESSMENT; TRAINING;

ANABOLIC AGENTS; GO/NO-GO; PUNISHMENT; RESPONSE INHIBITION; REWARD; RISK;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DECISION MAKING; IMPULSIVE BEHAVIOR; MALE; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; RISK-TAKING; SEXUAL MATURATION; TESTOSTERONE;

EID: 84893394507     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.11.017     Document Type: Article

References (61)

1. Ambar G., Chiavegatto S. Anabolic-androgenic steroid treatment induces behavioral disinhibition and down-regulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice. Genes Brain Behav. 2009, 8(2):161-173.
2. Bahrke M.S., Yesalis C.E. Abuse of anabolic-androgenic steroids and related substances in sport and exercise. Curr. Opin. Pharmacol. 2004, 4(6):614-620.
3. Bisschop A., Gayan-Ramirez G., Rollier H., Dekhuijzen P.N., Dom R., de Bock V., Decramer M. Effects of nandrolone decanoate on respiratory and peripheral muscles in male and female rats. J. Appl. Physiol. 1997, 82(4):1112-1118.
4. Breuer M.E., McGinnis M.Y., Lumia A.R., Possidente B.P. Aggression in male rats receiving anabolic-androgenic steroids: effects of social and environmental provocation. Horm. Behav. 2001, 40(3):409-418.
5. Cardinal R.N., Howes N.J. Effects of lesions of the nucleus accumbens core on choice between small certain rewards and large uncertain rewards in rats. BMC Neurosci. 2005, 6:37.
6. Celerier E., Yazdi M.T., Castane A., Ghozland S., Nyberg F., Maldonado R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur. J. Pharmacol. 2003, 465(1-2):69-81.
7. Chamberlain S.R., Sahakian B.J. The neuropsychiatry of impulsivity. Curr. Opin. Psychiatry 2007, 20:255-261.
8. Clark A.S., Blasberg M.E., Brandling-Bennett E.M. Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle. Physiol. Behav. 1998, 63(2):287-295.
9. Clark A.S., Fast A.S. Comparison of the effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats. Behav. Neurosci. 1996, 110(6):1478-1486.
10. Cocker P.J., Dinelle K., Kornelson R., Sossi V., Winstanley C.A. Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats. J. Neurosci. 2012, 32(44):15450-15457.
11. Creutz L.M., Kritzer M.F. Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. J. Comp. Neurol. 2004, 476(4):348-362.
12. Cunningham R.L., McGinnis M.Y. Physical provocation of pubertal anabolic-androgenic steroid-exposed male rats elicits aggression towards females. Horm. Behav. 2006, 50(3):410-416.
13. Eagle D.M., Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci. Biobehav. Rev. 2010, 34(1):50-72.
14. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berlin) 1999, 146(4):348-361.
15. Fardell J.E., Vardy J., Logge W., Johnston I. Single high-dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacol. Biochem. Behav. 2010, 97(2):333-339.
16. Farrell S.F., McGinnis M.Y. Effects of pubertal anabolic-androgenic steroid (AAS) administration on reproductive and aggressive behaviors in male rats. Behav. Neurosci. 2003, 117(5):904-911.
17. Farrell S.F., McGinnis M.Y. Long-term effects of pubertal anabolic-androgenic steroid exposure on reproductive and aggressive behaviors in male rats. Horm. Behav. 2004, 46(2):193-203.
18. FDA Guidance for Industry. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers 2005, Center for Drug Evaluation and Research, (accessed 11.07.13). http://www.fda.gov/downloads/Drugs/Guidances/UCM078932.pdf.
19. Ghods-Sharifi S., St Onge J.R., Floresco S.B. Fundamental contribution by the basolateral amygdala to different forms of decision making. J. Neurosci. 2009, 29(16):5251-5259.
20. Greenbaum K. Mood Changes Focus of Defense Testimony 1988, Sun-Sentinel, Deerfield Beach, FL, (accessed 20.11.13). http://articles.sun-sentinel.com/1988-06-08/news/8802030649_1_insanity-defense-horace-williams-violent-behavior.
21. Grimes J.M., Melloni R.H. Serotonin modulates offensive attack in adolescent anabolic steroid-treated hamsters. Pharmacol. Biochem. Behav. 2002, 73(3):713-721.
22. Gubner N.R., Wilhelm C.J., Phillips T.J., Mitchell S.H. Strain differences in behavioral inhibition in a go/no-go task demonstrated using 15 inbred mouse strains. Alcohol. Clin. Exp. Res. 2010, 34(8):1353-1362.
23. Kalis A., Mojzisch A., Schweizer T.S., Kaiser S. Weakness of will, akrasia, and the neuropsychiatry of decision making: an interdisciplinary perspective. Cogn. Affect. Behav. Neurosci. 2008, 8(4):402-417.
24. Kanayama G., Brower K.J., Wood R.I., Hudson J.I., Pope H.G. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009, 104(12):1966-1978.
25. Kanayama G., Hudson J.I., Pope H.G. Illicit anabolic-androgenic steroid use. Horm. Behav. 2010, 58(1):111-121.
26. Katz D.L., Pope H.G. Anabolic-androgenic steroid-induced mental status changes. NIDA Res. Monogr. 1990, 102:215-223.
27. Kindlundh A.M., Lindblom J., Nyberg F. Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain. Brain Res. 2003, 979(1-2):37-42.
28. Lindblom J., Kindlundh A.M., Nyberg F., Bergstrom L., Wikberg J.E. Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels. Brain Res. 2003, 986(1-2):139-147.
29. Liu J., Tsang S., Wong T.M. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 2006, 147(10):4569-4577.
30. Lynch W.J. Acquisition and maintenance of cocaine self-administration in adolescent rats: effects of sex and gonadal hormones. Psychopharmacology 2008, 197(2):237-246.
31. Lynch W.J. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacol. Biochem. Behav. 2009, 94(1):43-50.
32. McGinnis M.Y. Anabolic-androgenic steroids and aggression: studies using animal models. Ann. N. Y. Acad. Sci. 2004, 1036:399-415.
33. McGinnis M.Y., Lumia A.R., Breuer M.E., Possidente B. Physical provocation potentiates aggression in male rats receiving anabolic-androgenic steroids. Horm. Behav. 2002, 41(1):101-110.
34. Midgley S.J., Heather N., Davies J.B. Levels of aggression among a group of anabolic-androgenic steroid users. Med. Sci. Law 2001, 41(4):309-314.
35. Mobini S., Body S., Ho M.Y., Bradshaw C.M., Szabadi E., Deakin J.F., Anderson I.M. Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berlin) 2002, 160(3):290-298.
36. Moschak T.M., Mitchell S.H. Acute ethanol administration and reinforcer magnitude reduction both reduce responding and increase response latency in a go/no-go task. Alcohol. Clin. Exp. Res. 2012, 36(10):1803-1810.
37. Pagonis T.A., Angelopoulos N.V., Koukoulis G.N., Hadjichristodoulou C.S., Toli P.N. Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins. Eur. Psychiatry 2006, 21(8):563-569.
38. Pais-Vieira M., Lima D., Galhardo V. Orbitofrontal cortex lesions disrupt risk assessment in a novel serial decision-making task for rats. Neuroscience 2007, 145(1):225-231.
39. Pope H.G., Kanayama G., Athey A., Ryan E., Hudson J.I., Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am. J. Addict. 2013, (in press).
40. Pope H.G., Katz D.L. Homicide and near-homicide by anabolic steroid users. J. Clin. Psychiatry 1990, 51(1):28-31.
41. Pope H.G., Kouri E.M., Powell K.F., Campbell C., Katz D.L. Anabolic-androgenic steroid use among 133 prisoners. Compr. Psychiatry 1996, 37(5):322-327.
42. Ramirez J.M., Andreu J.M. Aggression, and some related psychological constructs (anger, hostility, and impulsivity); some comments from a research project. Neurosci. Biobehav. Rev. 2006, 30(3):276-291.
43. Rudebeck P.H., Walton M.E., Smyth A.N., Bannerman D.M., Rushworth M.F. Separate neural pathways process different decision costs. Nat. Neurosci. 2006, 9(9):1161-1168.
44. Sato S.M., Johansen J., Jordan C.L., Wood R.I. Membrane, not nuclear, androgen receptor mediates androgen reinforcement. Psychoneuroendocrinology 2010, 35(7):1063-1073.
45. Schulte H.M., Hall M.J., Boyer M. Domestic violence associated with anabolic steroid abuse. Am. J. Psychiatry 1993, 150(2):348.
46. Simon N.W., Gilbert R.J., Mayse J.D., Bizon J.L., Setlow B. Balancing risk and reward: a rat model of risky decision-making. Neuropsychopharmacology 2009, 34(10):2208-2217.
47. Simon N.W., Montgomery K.S., Beas B.S., Mitchell M.R., LaSarge C.L., Mendez I.A., Banuelos C., Vokes C.M., Taylor A.B., Haberman R.P., Bizon J.L., Setlow B. Dopaminergic modulation of risky decision-making. J. Neurosci. 2011, 31(48):17460-17470.
48. Simon N.W., Setlow B. Modeling risky decision-making in rodents. Methods Mol. Biol. 2012, 829:165-175.
49. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24(4):417-463.
50. St.Onge J.R., Abhari H., Floresco S.B. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. J. Neurosci. 2011, 31(23):8625-8633.
51. St.Onge J.R., Chiu Y.C., Floresco S.B. Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology 2010, 211(2):209-221.
52. St.Onge J.R., Floresco S.B. Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 2009, 34(3):681-697.
53. Summers J. Steroids 101 2003, Anabolics.com, Inc., Aurora, CO.
54. Tsutsui K.T., Wood R.I., Craft R.M. Anabolic-androgenic steroid effects on nociception and morphine antinociception in male rats. Pharmacol. Biochem. Behav. 2011, 99(3):500-508.
55. WADA, 2012. (accessed 05.02.13). http://www.wada-ama.org/Documents/Resources/Testing-Figures/WADA-2011-Laboratory-Testing-Figures.pdf.
56. Winstanley C.A. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br. J. Pharmacol. 2011, 164(4):1301-1321.
57. Winstanley C.A., Theobald D.E., Cardinal R.N., Robbins T.W. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J. Neurosci. 2004, 24(20):4718-4722.
58. Winstanley C.A., Theobald D.E., Dalley J.W., Cardinal R.N., Robbins T.W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb. Cortex 2006, 16(1):106-114.
59. Wood R.I., Armstrong A., Fridkin V., Shah V., Najafi A., Jakowec M. 'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylase. Physiol. Behav. 2013, 110-111:6-12.
60. Wood R.I., Stanton S.J. Testosterone and sport: current perspectives. Horm. Behav. 2012, 61(1):147-155.
61. Young J.W., van Enkhuizen J., Winstanley C.A., Geyer M.A. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J. Psychopharmacol. 2011, 25(7):934-943.